Axcan Pharma Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Axcan Pharma is a leading specialty pharmaceutical company that develops and markets a range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Axcan's strategy is to grow its business by increasing market penetration and sales of existing products, developing and obtaining marketing approval for new products, in-licensing products and acquiring new products or companies, development of its research and development portfolio, and expanding geographically.

    Currently, the company markets more than 40 products and dosage strengths worldwide in the field of gastroenterology. Axcan's major products include Ultrase (Pancreatic Diseases), Urso (Cirrhosis), Canasa (Proctitis) and Carafate (Duodenal Ulcer).

    Axcan's all of the revenue has historically been and continues to be principally derived from sales of pharmaceutical products. The company's total revenues increased at a CAGR of 22% during 2002-2006, from $132 million to $292 million.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: axcan pharma ultrase lacteol competitor pipeline sales forte pharmaceutical company

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.